David I. Hong

2.1k total citations · 1 hit paper
15 papers, 1.2k citations indexed

About

David I. Hong is a scholar working on Pharmacology, Immunology and Physiology. According to data from OpenAlex, David I. Hong has authored 15 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 5 papers in Immunology and 4 papers in Physiology. Recurrent topics in David I. Hong's work include Drug-Induced Adverse Reactions (10 papers), Asthma and respiratory diseases (4 papers) and Immune Cell Function and Interaction (3 papers). David I. Hong is often cited by papers focused on Drug-Induced Adverse Reactions (10 papers), Asthma and respiratory diseases (4 papers) and Immune Cell Function and Interaction (3 papers). David I. Hong collaborates with scholars based in United States, Slovakia and Canada. David I. Hong's co-authors include Valarie A. Barr, Stephen C. Bunnell, Lawrence E. Samelson, Tetsuo Yamazaki, C. Jane McGlade, Julia R. Kardon, Mariana Castells, David E. E. Sloane, Nora A. Barrett and Ursula A. Matulonis and has published in prestigious journals such as The Journal of Cell Biology, The Journal of Immunology and Molecular and Cellular Biology.

In The Last Decade

David I. Hong

15 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

T cell receptor ligation induces the formation of dynamically regulated signaling assemblies

2002 515 citations Stephen C. Bunnell, David I. Hong et al. The Journal of Cell Biology profile →

Peers

David I. Hong

IMMUN

PHARM

MB

IA

ONCOL

Anthony Shock United Kingdom

Lihe Su United States

Joseph R. Woska United States

Kimberly A. Solomon United States

Hendra Setiadi United States

Keiji Tanese Japan

Gregory J. Carven United States

Julius Kahn United States

Ayman Rahman United States

Daren Shi China

Anthony Shock United Kingdom

David I. Hong

482 ×0.9

IMMUN

24 ×0.1

PHARM

257 ×1.1

MB

302 ×1.4

IA

114 ×0.6

ONCOL

Citations per year, relative to David I. Hong David I. Hong (= 1×) peers Anthony Shock

Countries citing papers authored by David I. Hong

Since Specialization

Citations

This map shows the geographic impact of David I. Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David I. Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David I. Hong more than expected).

Fields of papers citing papers by David I. Hong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David I. Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David I. Hong. The network helps show where David I. Hong may publish in the future.

Co-authorship network of co-authors of David I. Hong

This figure shows the co-authorship network connecting the top 25 collaborators of David I. Hong. A scholar is included among the top collaborators of David I. Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David I. Hong. David I. Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Tuttle, Katherine R., et al.. (2021). Oxaliplatin hypersensitivity complicated by thrombocytopenia during desensitization. Annals of Allergy Asthma & Immunology. 127(2). 267–269. 2 indexed citations

2.

Hong, David I., Ricardo Madrigal‐Burgaleta, Aleena Banerji, Mariana Castells, & Emilio Álvarez-Cuesta. (2020). Controversies in Allergy: Chemotherapy Reactions, Desensitize, or Delabel?. The Journal of Allergy and Clinical Immunology In Practice. 8(9). 2907–2915.e1. 30 indexed citations

3.

Hong, David I. & David E. E. Sloane. (2019). Hypersensitivity to monoclonal antibodies used for cancer and inflammatory or connective tissue diseases. Annals of Allergy Asthma & Immunology. 123(1). 35–41. 18 indexed citations

4.

Hong, David I.. (2019). Desensitization for Allergic Reactions to Chemotherapy. Yonsei Medical Journal. 60(2). 119–119. 20 indexed citations

5.

Hong, David I.. (2018). Omalizumab As Adjuvant Therapy in Chemotherapy Desensitization. Journal of Allergy and Clinical Immunology. 141(2). AB410–AB410. 1 indexed citations

6.

Tuttle, Katherine R., Marlene Garcia-Neuer, Nathan T. Connell, et al.. (2017). Oxaliplatin Induced Immune Thrombocytopenia in Patients with Oxaliplatin Hypersensitivity: Implications for Desensitization. Journal of Allergy and Clinical Immunology. 139(2). AB41–AB41. 1 indexed citations

7.

Wickner, Paige G. & David I. Hong. (2016). Immediate Drug Hypersensitivity. Current Allergy and Asthma Reports. 16(7). 49–49. 2 indexed citations

8.

Hong, David I. & Anahita F. Dioun. (2014). Indications, Protocols, and Outcomes of Drug Desensitizations for Chemotherapy and Monoclonal Antibodies in Adults and Children. The Journal of Allergy and Clinical Immunology In Practice. 2(1). 13–19. 30 indexed citations

9.

Hong, David I., Lora G. Bankova, Katherine N. Cahill, Timothy Kyin, & Mariana Castells. (2011). Allergy to monoclonal antibodies: cutting-edge desensitization methods for cutting-edge therapies. Expert Review of Clinical Immunology. 8(1). 43–54. 60 indexed citations

10.

Breslow, Rebecca G., et al.. (2009). Inhibition of Th2 Adaptive Immune Responses and Pulmonary Inflammation by Leukocyte Ig-Like Receptor B4 on Dendritic Cells. The Journal of Immunology. 184(2). 1003–1013. 12 indexed citations

11.

Castells, Mariana, David E. E. Sloane, Florence Ida Hsu, et al.. (2008). Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases. Journal of Allergy and Clinical Immunology. 122(3). 574–580. 408 indexed citations

12.

Witzmann, Frank A., et al.. (2008). Changes in cell function and protein expression of mouse renal principal cells, mpkCCD, after carbon nanoparticle (CNP) exposure. The FASEB Journal. 22(S1). 1 indexed citations

13.

Witzmann, Frank A., David I. Hong, Zachary A. Rodd, et al.. (2007). Synaptosomal protein expression in nucleus accumbens after EtOH self‐administration in the posterior VTA. The FASEB Journal. 21(5). 1 indexed citations

14.

Bunnell, Stephen C., Andrew L. Singer, David I. Hong, et al.. (2006). Persistence of Cooperatively Stabilized Signaling Clusters Drives T-Cell Activation. Molecular and Cellular Biology. 26(19). 7155–7166. 103 indexed citations

15.

Bunnell, Stephen C., David I. Hong, Julia R. Kardon, et al.. (2002). T cell receptor ligation induces the formation of dynamically regulated signaling assemblies. The Journal of Cell Biology. 158(7). 1263–1275. 515 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact